Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Synopsis of Salvianolic Acid Use in Arteriosclerosis

Salvianolic acid, primarily derived from the roots of Salvia miltiorrhiza (Danshen), has been traditionally used in Chinese medicine for cardiovascular and cerebrovascular disorders. Recent scientific studies have investigated its potential benefits in the context of arteriosclerosis, a condition characterized by the thickening and stiffening of arterial walls.

Preclinical research demonstrates that salvianolic acid, especially salvianolic acid B, exhibits antioxidant, anti-inflammatory, and anti-thrombotic properties. These effects are thought to be beneficial in slowing the progression of arteriosclerosis. Mechanistically, salvianolic acid has been shown to inhibit the oxidation of low-density lipoprotein (LDL), suppress vascular smooth muscle cell proliferation, and reduce endothelial dysfunction—all key factors in arteriosclerosis development (Wang et al., 2015; Zhou et al., 2010).

However, the majority of evidence comes from in vitro and animal studies. Human clinical trials are limited in number, small in scale, and often lack rigorous design. Therefore, while there is a plausible scientific basis and early-stage evidence supporting salvianolic acid’s role in mitigating arteriosclerosis, high-quality clinical data are insufficient to draw firm conclusions or recommend its routine use for this condition.

In summary, the use of salvianolic acid for arteriosclerosis is supported by preliminary scientific evidence, but its clinical effectiveness and safety require further validation in large, well-controlled human studies.

More about Salvianolic acid
More about Arteriosclerosis

Other ingredients used for Arteriosclerosis

Other health conditions supported by Salvianolic acid

Products containing Salvianolic acid